We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Resistance in Enterobacterales Is Higher Among People Living With Human Immunodeficiency Virus.
- Authors
Henderson, Heather I; Napravnik, Sonia; Gower, Emily W; Aiello, Allison E; Kinlaw, Alan C; Williams, Billy; Wohl, David A; Duin, David van
- Abstract
Background Multidrug-resistant Enterobacterales (MDR-E) are important pathogens. People living with human immunodeficiency virus (HIV; PLWH) may be at greater risk for MDR-E infection given relatively high antibiotic exposure and burden of comorbidities. Methods We analyzed data from 36 521 patients in a healthcare system in North Carolina who had a clinical culture with growth of an Enterobacterales species from 2000 to 2018; 440 were PLWH. We used generalized linear models to estimate prevalence ratios and differences, contrasting PLWH and people not living with HIV (PNLWH) for resistance to individual antibiotic classes, as well as MDR-E. We assessed trends in prevalence over time by calculating the 5-year moving average and fitting restricted cubic spline models. Results The overall prevalence of MDR-E was higher among PLWH (21.5%; 95% confidence interval [CI], 18.2%–25.1%) vs PNLWH (16.5%; 95% CI, 16.2%–16.9%), with an adjusted prevalence ratio of 1.38 (95% CI, 1.14–1.65). PLWH had higher rates of antimicrobial resistance than PNLWH for all antibiotic classes analyzed, including penicillins, penicillin/beta lactamase inhibitor combinations, and sulfonamides. MDR-E prevalence was 3 to 10 percentage points higher among PLWH than PNLWH throughout the study period based on the 5-year moving average. Conclusions In a large clinical study population in the southeastern United States from 2000 to 2018, the prevalence of antibacterial resistance among Enterobacterales was consistently higher among PLWH than PNLWH. These data highlight the importance of identifying and mitigating the factors that contribute to antimicrobial resistance in PLWH, given the potential clinical consequences of these resistant pathogens.
- Subjects
NORTH Carolina; ANTIBIOTICS; HIV infections; HIV-positive persons; STATISTICS; CONFIDENCE intervals; ENTEROBACTERIACEAE diseases; PENICILLIN; BETA lactamases; RESEARCH funding; DRUG resistance in microorganisms; DATA analysis; COMORBIDITY; CHEMICAL inhibitors; DISEASE risk factors
- Publication
Clinical Infectious Diseases, 2022, Vol 75, Issue 1, p28
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciab901